By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Bio-View Ltd (BIOV.TA)

TLV Market Data in ILA, Fundamentals in ILS
ILA 22.50
+ILA 0.70
+3.21%
Last Update: 17 Sept 2025, 07:33
ILA 31.27M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
ILA 18.30 - ILA 36.00
52 Week Range

BIOV.TA Stock Price Chart

Explore Bio-View Ltd interactive price chart. Choose custom timeframes to analyze BIOV.TA price movements and trends.

BIOV.TA Company Profile

Discover essential business fundamentals and corporate details for Bio-View Ltd (BIOV.TA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

12 Mar 2006

Employees

33.00

CEO

Yuval Harari

Description

Bio-View Ltd develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. Its products include Accord, a workbench microscope station for semi-automated fluorescent imaging and analysis; Accord Plus, an automatic fluorescent imaging system that automatically scans, analyses, and sorts a range of FISH samples in real-time; and Allegro Plus, an automatic fluorescent imaging system, which identifies various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. It also offers DUET-3, an imaging and analysis platform that include an automated barcode reader, which enables scanning of various test types in a single scan batch; DeNovo, an automated scanning system for detection, analysis, and characterization of circulating tumor cells from peripheral blood; Solo Workstation, an offline workstation that streamlines and enables review and analysis of test results away from the microscope; Solo Touch Workstation, a stand-alone workstation with advanced review and analysis tools; and SoloWeb, a Web-based solution that provides analysis, reporting, and consulting on BioView-scanned cases. Bio-View Ltd has a partnership agreement with ANGLE plc to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 2000 and is headquartered in Rehovot, Israel.

BIOV.TA Financial Timeline

Browse a chronological timeline of Bio-View Ltd corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 9 Dec 2024

EPS came in at ILA 0.01 , while revenue for the quarter reached ILA 8.52M .

Earnings released on 31 Mar 2024

EPS came in at ILA 0.01 , while revenue for the quarter reached ILA 8.52M .

Earnings released on 31 Dec 2023

EPS came in at -ILA 0.00 , while revenue for the quarter reached ILA 8.65M .

Stock split effective on 24 Dec 2023

Shares were split 10 : 1 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2023

EPS came in at -ILA 0.00 , while revenue for the quarter reached ILA 8.65M .

Earnings released on 30 Jun 2023

EPS came in at ILA 0.01 , while revenue for the quarter reached ILA 8.73M .

Earnings released on 31 Mar 2023

EPS came in at ILA 0.01 , while revenue for the quarter reached ILA 8.73M .

Earnings released on 31 Dec 2022

EPS came in at -ILA 0.04 , while revenue for the quarter reached ILA 8.26M .

Earnings released on 30 Sept 2022

EPS came in at ILA 0.08 , while revenue for the quarter reached ILA 8.39M .

Earnings released on 30 Jun 2022

EPS came in at -ILA 0.03 , while revenue for the quarter reached ILA 5.51M .

Earnings released on 31 Mar 2022

EPS came in at ILA 0.03 , while revenue for the quarter reached ILA 6.98M .

Earnings released on 31 Dec 2021

EPS came in at ILA 0.00 , while revenue for the quarter reached ILA 8.20M .

Earnings released on 30 Sept 2021

EPS came in at ILA 0.08 , while revenue for the quarter reached ILA 9.05M .

Earnings released on 30 Jun 2021

EPS came in at ILA 0.00 , while revenue for the quarter reached ILA 5.83M .

Earnings released on 31 Mar 2021

EPS came in at ILA 0.06 , while revenue for the quarter reached ILA 7.44M .

Earnings released on 31 Dec 2020

EPS came in at -ILA 0.02 , while revenue for the quarter reached ILA 7.24M .

Earnings released on 30 Sept 2020

EPS came in at ILA 0.12 , while revenue for the quarter reached ILA 7.61M .

BIOV.TA Stock Performance

Access detailed BIOV.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run